Synucure Therapeutics Revenue

Biotechnology Research • Montreal, Quebec, Canada • 1-10 Employees

Synucure Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	$2,800,000

Key Contact at Synucure Therapeutics

Norma Beauchamp

Independent Director

Company overview

Headquarters	Montreal, Quebec, Canada
Website	synucure.com
NAICS	541714
Founded	2021
Employees	1-10

Synucure Therapeutics Email Formats

Synucure Therapeutics uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@synucure.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@synucure.com	100%

About Synucure Therapeutics

Synucure Therapeutics inc. is a Canadian biotechnology company conducting research in brain degenerative disorders. Synucure was founded in 2021 with the key objective to pursue the promising and robust pre-clinical work of Dr. Francesca Cicchetti on a repurposed drug called Cysteamine which demonstrated, in various animal and cell models, that the drug could prevent and/or reverse a number of features related to Parkinson’s Disease (PD). Her research on the potential benefits of Cysteamine in neurodegenerative disorders was initiated 20 years ago. In addition to the promising role of Cysteamine as a Disease Modifying Therapy (DMT) in Parkinson, Dr. Cicchetti and her colleagues conducted research on patented blood biomarkers, of which the main objective is to provide clinicians with a more precise diagnostic and stratification tool for the disease using a simple blood test. If you need more information, please contact us at info@synucure.com

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Synucure Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-05-07	3	$2,800,000

Funding Insights

$2,800,000

Total funding amount

$2,800,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Synucure Therapeutics is located in Montreal, Quebec, CA.

Synucure Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Synucure Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Synucure Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Synucure Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Synucure Therapeutics has raised a total of $2,800,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Synucure Therapeutics

Norma Beauchamp

Independent Director

4.8

40,000 users